Back to search

Article

Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certainty

2023-10-10

Abstract excerpt

Sodium-glucose cotransporter inhibitors (SGLT2 inhibitors) are novel drugs in the treatment of type 2 diabetes mellitus that prevent the absorption of glucose in the proximal tubules of the kidney and lower the blood glucose level. In addition to treating diabetes type 2, it influences all human systems. The aim of this study is to evaluate the effects of this drug (either beneficial or adverse) on all human syste...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c778ad96-26a8-56ec-b751-5708c930c2e3
DOI
10.22541/au.169691547.73014056/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certaintyDOI 10.22541/au.169691547.73014056/v1
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity
Update on the use of Sodium Glucose Cotransporter Type 2 inhibitors in kidney transplant patientsSemantic proximity
Efficacy and safety of SGLT2 inhibitors in the treatment of heart failure-May raise creatinine levels in patients: A meta-analysisSemantic proximity
SGLT2 Inhibitors and Potential Applications in Treating Metabolic SyndromeSemantic proximity
Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update.Semantic proximity
A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated ComorbiditiesSemantic proximity
Nonglycemic Effects of SGLT2 Inhibitors: Focus on Inflammation and MacrophagesSemantic proximity
Development of SGLT1 and SGLT2 inhibitors.Semantic proximity
Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics.Semantic proximity
Renal outcomes of combination therapy with sodium-glucose cotransporter 2 inhibitors plus renin-angiotensin system blockers in patients with type 2 diabetes mellitus: A population-based cohort studySemantic proximity
From Malaria Fighter to Diabetes Guardian: The Emerging Role of Artesunate in Treating Diabetes and Diabetic ComplicationsSemantic proximity
Treatment Response to SGLT2 Inhibitors: From Clinical Characteristics to Genetic VariationsSemantic proximity
Select a neighboring publication to make it the new centre.